Diabetes, Vol 46, Issue 2 209-214, Copyright © 1997 by American Diabetes Association

ARTICLES

Adrenalectomy prevents the obesity syndrome produced by chronic central neuropeptide Y infusion in normal rats

A Sainsbury, I Cusin, F Rohner-Jeanrenaud and B Jeanrenaud
Laboratoires de Recherches Metaboliques, Faculty of Medicine, University of Geneva, Switzerland.

Neuropeptide Y (NPY) in the hypothalamus plays an important role in the regulation of food intake and body weight and seems to be implicated in the etiology of obesity. When intracerebroventricularly (ICV) infused for 6 days in normal rats, NPY resulted in hyperphagia, increased body weight gain, hyperinsulinemia, hypercorticosteronemia, and hypertriglyceridemia compared with vehicle-infused control rats. NPY infusion also resulted in an insulin-resistant state in muscles and in a state of insulin hyperresponsiveness in white adipose tissue, as assessed by the measurement of the in vivo glucose utilization index of these tissues during euglycemic-hyperinsulinemic clamps. All of these hormono-metabolic effects produced by chronic central NPY infusion were completely prevented when rats were adrenalectomized before NPY administration. Adrenalectomy per se had no effect on any of the parameters mentioned above. The levels of mRNA for the obese gene were increased in white adipose tissue after 6 days of ICV NPY infusion in normal rats, and white adipose tissue weight was also increased. These effects of ICV NPY infusion were markedly decreased by prior adrenalectomy, although NPY infusion was able to somewhat enhance the low white adipose tissue obese mRNA levels and tissue weight of adrenalectomized rats. In conclusion, intact adrenal glands, and probably circulating corticosterone in particular, are necessary for the establishment of most of the hormonal and metabolic effects induced by chronic ICV infusion of NPY in normal rats.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. M. van den Hoek, C. van Heijningen, J. P. Schroder-van der Elst, D. M. Ouwens, L. M. Havekes, J. A. Romijn, A. Kalsbeek, and H. Pijl Intracerebroventricular Administration of Neuropeptide Y Induces Hepatic Insulin Resistance via Sympathetic Innervation Diabetes, September 1, 2008; 57(9): 2304 - 2310. [Abstract] [Full Text] [PDF]

				Z. Michailidou, A. P Coll, C. J Kenyon, N. M Morton, S. O'Rahilly, J. R Seckl, and K. E Chapman Peripheral mechanisms contributing to the glucocorticoid hypersensitivity in proopiomelanocortin null mice treated with corticosterone J. Endocrinol., July 1, 2007; 194(1): 161 - 170. [Abstract] [Full Text] [PDF]

				P. A. Baldock, S. J. Allison, P. Lundberg, N. J. Lee, K. Slack, E.-J. D. Lin, R. F. Enriquez, M. M. McDonald, L. Zhang, M. J. During, et al. Novel Role of Y1 Receptors in the Coordinated Regulation of Bone and Energy Homeostasis J. Biol. Chem., June 29, 2007; 282(26): 19092 - 19102. [Abstract] [Full Text] [PDF]

				N. Kakui and K. Kitamura Direct Evidence that Stimulation of Neuropeptide Y Y5 Receptor Activates Hypothalamo-Pituitary-Adrenal Axis in Conscious Rats via both Corticotropin-Releasing Factor- and Arginine Vasopressin-Dependent Pathway Endocrinology, June 1, 2007; 148(6): 2854 - 2862. [Abstract] [Full Text] [PDF]

				E.-J. D. Lin, A. Sainsbury, N. J. Lee, D. Boey, M. Couzens, R. Enriquez, K. Slack, R. Bland, M. J. During, and H. Herzog Combined Deletion of Y1, Y2, and Y4 Receptors Prevents Hypothalamic Neuropeptide Y Overexpression-Induced Hyperinsulinemia despite Persistence of Hyperphagia and Obesity Endocrinology, November 1, 2006; 147(11): 5094 - 5101. [Abstract] [Full Text] [PDF]

				A. P. Coll, B. G. Challis, M. Lopez, S. Piper, G. S.H. Yeo, and S. O'Rahilly Proopiomelanocortin-Deficient Mice Are Hypersensitive to the Adverse Metabolic Effects of Glucocorticoids Diabetes, August 1, 2005; 54(8): 2269 - 2276. [Abstract] [Full Text] [PDF]

				S. Boullu-Ciocca, A. Dutour, V. Guillaume, V. Achard, C. Oliver, and M. Grino Postnatal Diet-Induced Obesity in Rats Upregulates Systemic and Adipose Tissue Glucocorticoid Metabolism During Development and in Adulthood: Its Relationship With the Metabolic Syndrome Diabetes, January 1, 2005; 54(1): 197 - 203. [Abstract] [Full Text] [PDF]

				S. Deshmukh, B. G. Phillips, T. O'Dorisio, M. J. Flanigan, and V. S. Lim Hormonal responses to fasting and refeeding in chronic renal failure patients Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E47 - E55. [Abstract] [Full Text] [PDF]

				A. M. van den Hoek, P. J. Voshol, B. N. Karnekamp, R. M. Buijs, J. A. Romijn, L. M. Havekes, and H. Pijl Intracerebroventricular Neuropeptide Y Infusion Precludes Inhibition of Glucose and VLDL Production by Insulin Diabetes, October 1, 2004; 53(10): 2529 - 2534. [Abstract] [Full Text] [PDF]

				A. M. van den Hoek, A. C. Heijboer, E. P.M. Corssmit, P. J. Voshol, J. A. Romijn, L. M. Havekes, and H. Pijl PYY3-36 Reinforces Insulin Action on Glucose Disposal in Mice Fed a High-Fat Diet Diabetes, August 1, 2004; 53(8): 1949 - 1952. [Abstract] [Full Text] [PDF]

				S. E. la Fleur, S. F. Akana, S. L. Manalo, and M. F. Dallman Interaction between Corticosterone and Insulin in Obesity: Regulation of Lard Intake and Fat Stores Endocrinology, May 1, 2004; 145(5): 2174 - 2185. [Abstract] [Full Text] [PDF]

				J. Q. Purnell, D. D. Brandon, L. M. Isabelle, D. L. Loriaux, and M. H. Samuels Association of 24-Hour Cortisol Production Rates, Cortisol-Binding Globulin, and Plasma-Free Cortisol Levels with Body Composition, Leptin Levels, and Aging in Adult Men and Women J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 281 - 287. [Abstract] [Full Text] [PDF]

				F. Elefteriou, S. Takeda, X. Liu, D. Armstrong, and G. Karsenty Monosodium Glutamate-Sensitive Hypothalamic Neurons Contribute to the Control of Bone Mass Endocrinology, September 1, 2003; 144(9): 3842 - 3847. [Abstract] [Full Text] [PDF]

				X.-Y. Lu, K.-R. Shieh, M. Kabbaj, G. S. Barsh, H. Akil, and S. J. Watson Diurnal Rhythm of Agouti-Related Protein and Its Relation to Corticosterone and Food Intake Endocrinology, October 1, 2002; 143(10): 3905 - 3915. [Abstract] [Full Text] [PDF]

				C. Kellendonk*, S. Eiden*, O. Kretz, G. Schutz, I. Schmidt, F. Tronche, and E. Simon Inactivation of the GR in the Nervous System Affects Energy Accumulation Endocrinology, June 1, 2002; 143(6): 2333 - 2340. [Abstract] [Full Text] [PDF]

				C. J. Small, M. S. Kim, S. A. Stanley, J. R.D. Mitchell, K. Murphy, D. G.A. Morgan, M. A. Ghatei, and S. R. Bloom Effects of Chronic Central Nervous System Administration of Agouti-Related Protein in Pair-Fed Animals Diabetes, February 1, 2001; 50(2): 248 - 254. [Abstract] [Full Text]

				K. E. Zakrzewska, A. Sainsbury, I. Cusin, J. Rouru, B. Jeanrenaud, and F. Rohner-Jeanrenaud Selective Dependence of Intracerebroventricular Neuropeptide Y-Elicited Effects on Central Glucocorticoids Endocrinology, July 1, 1999; 140(7): 3183 - 3187. [Abstract] [Full Text]

				E. Jequier and L. Tappy Regulation of Body Weight in Humans Physiol Rev, April 1, 1999; 79(2): 451 - 480. [Abstract] [Full Text] [PDF]